Stavanger University Hospital Inflammatory Bowel Disease Trial (SUSI)
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.
Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue|
- Clinical efficacy of IBD drug therapy [ Time Frame: 1 year ] [ Designated as safety issue: No ]Endoscopic, clinical and biochemical response
Biospecimen Retention: Samples With DNA
Plasma and mucosal biopsies
|Study Start Date:||April 2012|
|Estimated Study Completion Date:||December 2014|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|
none considered needed
Please refer to this study by its ClinicalTrials.gov identifier: NCT01551563
|Contact: Tore B Grimstad, MD PhD +47909 21 650|